These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 18161784)

  • 1. Danazol therapy for aplastic anemia refractory to immunosuppressive therapy.
    Chuhjo T; Yamazaki H; Omine M; Nakao S
    Am J Hematol; 2008 May; 83(5):387-9. PubMed ID: 18161784
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of paroxysmal nocturnal hemoglobinuria clones in response to immunosuppressive therapy of patients with severe aplastic anemia.
    Zhao X; Zhang L; Jing L; Zhou K; Li Y; Peng G; Ye L; Li Y; Li J; Fan H; Song L; Yang W; Zhang F
    Ann Hematol; 2015 Jul; 94(7):1105-10. PubMed ID: 25784221
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Danazol as first-line therapy for aplastic anemia.
    Jaime-Pérez JC; Colunga-Pedraza PR; Gómez-Ramírez CD; Gutiérrez-Aguirre CH; Cantú-Rodríguez OG; Tarín-Arzaga LC; Gómez-Almaguer D
    Ann Hematol; 2011 May; 90(5):523-7. PubMed ID: 21279356
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of paroxysmal nocturnal haemoglobinuria clone presence in aplastic anaemia patients treated with combined immunosuppression: results of two-centre prospective study.
    Kulagin A; Lisukov I; Ivanova M; Golubovskaya I; Kruchkova I; Bondarenko S; Vavilov V; Stancheva N; Babenko E; Sipol A; Pronkina N; Kozlov V; Afanasyev B
    Br J Haematol; 2014 Feb; 164(4):546-54. PubMed ID: 24261566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hematologic recovery induced by eltrombopag in Japanese patients with aplastic anemia refractory or intolerant to immunosuppressive therapy.
    Yamazaki H; Ohta K; Iida H; Imada K; Obara N; Tokumine Y; Tomiyama Y; Usuki K; Imajo K; Miyamura K; Sasaki O; Fanghong Z; Hattori T; Tajima T; Matsuda A; Nakao S
    Int J Hematol; 2019 Aug; 110(2):187-196. PubMed ID: 31183813
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of immunosuppressive therapy in a patient with aplastic anemia-paroxysmal nocturnal hemoglobinuria (AA-PNH) syndrome during ongoing eculizumab treatment.
    Asano J; Ueda R; Tanaka Y; Shinzato I; Takafuta T
    Intern Med; 2014; 53(2):125-8. PubMed ID: 24429452
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The variation and clinical significance of paroxysmal nocturnal hemoglobinuria clone in patients with aplastic anemia before and after immunosuppressive therapy].
    Sun YX; Zhu MQ; He GS; Wang XL; Fang BZ; Lu C; Liu ZZ; Wu Q; Yang Y; Wu DP; Sun AN
    Zhonghua Nei Ke Za Zhi; 2013 Jul; 52(7):585-9. PubMed ID: 24267002
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunosuppressive therapy in patients with aplastic anemia: a single-center retrospective study.
    Jalaeikhoo H; Khajeh-Mehrizi A
    PLoS One; 2015; 10(5):e0126925. PubMed ID: 25970182
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The predictive value of pre-treatment paroxysmal nocturnal hemoglobinuria clone on response to immunosuppressive therapy in patients with aplastic anemia: a meta-analysis.
    Wang B; He B; Zhu YD; Wu W
    Hematology; 2020 Dec; 25(1):464-472. PubMed ID: 33269994
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Significance of paroxysmal nocturnal hemoglobinuria clone in immunosuppressive therapy for children with severe aplastic anemia.
    Li J; Zong SY; Yin ZX; Gao YY; Liu LP; Wan Y; Lan Y; Gong XW; Zhu XF
    Zhongguo Dang Dai Er Ke Za Zhi; 2022 Mar; 24(3):303-308. PubMed ID: 35351262
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of idiopathic thrombocytopenic purpura (ITP) in patients with refractoriness to or with contraindication for corticosteroids and/or splenectomy with immunosuppressive therapy and danazol.
    Schiavotto C; Castaman G; Rodeghiero F
    Haematologica; 1993; 78(6 Suppl 2):29-34. PubMed ID: 8039755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Paroxysmal nocturnal haemoglobinuria phenotype cells and leucocyte subset telomere length in childhood acquired aplastic anaemia.
    Tutelman PR; Aubert G; Milner RA; Dalal BI; Schultz KR; Deyell RJ
    Br J Haematol; 2014 Mar; 164(5):717-21. PubMed ID: 24236830
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Danazol increases T regulatory cells in patients with aplastic anemia.
    Khurana H; Malhotra P; Sachdeva MU; Varma N; Bose P; Yanamandra U; Varma S; Khadwal A; Lad D; Prakash G
    Hematology; 2018 Sep; 23(8):496-500. PubMed ID: 29415633
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Paroxysmal nocturnal hemoglobinuria clones in children with acquired aplastic anemia: a multicentre study.
    Timeus F; Crescenzio N; Longoni D; Doria A; Foglia L; Pagliano S; Vallero S; Decimi V; Svahn J; Palumbo G; Ruggiero A; Martire B; Pillon M; Marra N; Dufour C; Ramenghi U; Saracco P
    PLoS One; 2014; 9(7):e101948. PubMed ID: 25007335
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Diagnosis and treatment of aquired aplastic anemia].
    Kulagin AD; Lisukov IA; Kriuchkova IV; Sizikova SA; Gilevich AV; Denisova VV; Filimonov PN; Meniaeva EV; Pronkina NV; Kozhevnikov VS; Chernykh ER; Kozlov VA
    Ter Arkh; 2006; 78(11):48-54. PubMed ID: 17195527
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pilot study using tacrolimus rather than cyclosporine plus antithymocyte globulin as an immunosuppressive therapy regimen option for severe aplastic anemia in adults.
    Zhu X; Guan J; Xu J; Wei J; Jiang L; Yin J; Zhao L; Zhang Y
    Blood Cells Mol Dis; 2014 Sep; 53(3):157-60. PubMed ID: 24931461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Danazol for paroxysmal nocturnal hemoglobinuria.
    Harrington WJ; Kolodny L; Horstman LL; Jy W; Ahn YS
    Am J Hematol; 1997 Feb; 54(2):149-54. PubMed ID: 9034290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Treatment of paroxysmal nocturnal hemoglobinuria with danazol].
    Yoshimura Y; Nakayama A; Hama H; Oguchi J; Matsuda J; Kamakura M; Kinoshita T; Yamanaka M; Abe T
    Rinsho Ketsueki; 1990 Sep; 31(9):1489-92. PubMed ID: 2246821
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Paroxysmal nocturnal hemoglobinuria and telomere length predicts response to immunosuppressive therapy in pediatric aplastic anemia.
    Narita A; Muramatsu H; Sekiya Y; Okuno Y; Sakaguchi H; Nishio N; Yoshida N; Wang X; Xu Y; Kawashima N; Doisaki S; Hama A; Takahashi Y; Kudo K; Moritake H; Kobayashi M; Kobayashi R; Ito E; Yabe H; Ohga S; Ohara A; Kojima S;
    Haematologica; 2015 Dec; 100(12):1546-52. PubMed ID: 26315930
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relapse and clonal disease in children with aplastic anemia (AA) after immunosuppressive therapy (IST): the SAA 94 experience. German/Austrian Pediatric Aplastic Anemia Working Group.
    Führer M; Burdach S; Ebell W; Gadner H; Haas R; Harbott J; Janka-Schaub G; Klingebiel T; Kremens B; Niemeyer C; Rampf U; Reiter A; Ritter J; Schulz A; Walther U; Zeidler C; Bender-Götze C
    Klin Padiatr; 1998; 210(4):173-9. PubMed ID: 9743949
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.